Core Insights - Kornit Digital (KRNT) reported quarterly earnings of $0.03 per share, exceeding the Zacks Consensus Estimate of $0.02 per share, and showing an increase from $0.02 per share a year ago, resulting in an earnings surprise of +50.00% [1] - The company posted revenues of $49.75 million for the quarter ended June 2025, which was 4.35% below the Zacks Consensus Estimate, but an increase from $48.62 million year-over-year [2] - Kornit Digital has surpassed consensus EPS estimates three times over the last four quarters, while also topping revenue estimates three times in the same period [2] Earnings Outlook - The future performance of Kornit Digital's stock will largely depend on management's commentary during the earnings call and the sustainability of the stock's immediate price movement based on the recently released numbers [3][4] - The current consensus EPS estimate for the upcoming quarter is $0.09 on revenues of $57.34 million, and for the current fiscal year, it is $0.31 on revenues of $222.46 million [7] Industry Context - The Commercial Printing industry, to which Kornit Digital belongs, is currently ranked in the top 13% of over 250 Zacks industries, indicating a favorable outlook compared to the bottom 50% [8] - Empirical research suggests a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can be tracked by investors [5]

Company Performance - Middleby (MIDD) reported quarterly earnings of $2.35 per share, exceeding the Zacks Consensus Estimate of $2.20 per share, but down from $2.39 per share a year ago, representing an earnings surprise of +6.82% [1] - The company posted revenues of $977.86 million for the quarter ended June 2025, surpassing the Zacks Consensus Estimate by 0.31%, but down from $991.55 million year-over-year [2] - Over the last four quarters, Middleby has surpassed consensus EPS estimates three times and topped consensus revenue estimates two times [2] Stock Outlook - Middleby shares have increased approximately 6.8% since the beginning of the year, compared to the S&P 500's gain of 7.1% [3] - The company's earnings outlook, including current consensus earnings expectations for upcoming quarters, will be crucial for investors [4] - The current consensus EPS estimate for the coming quarter is $2.24 on revenues of $971.84 million, and for the current fiscal year, it is $9.19 on revenues of $3.89 billion [7] Industry Context - The Manufacturing - General Industrial industry, to which Middleby belongs, is currently ranked in the top 16% of over 250 Zacks industries, indicating a favorable outlook [8] - Empirical research suggests a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can impact Middleby's stock performance [5]

Company Performance - Arvinas, Inc. reported a quarterly loss of $0.84 per share, which was better than the Zacks Consensus Estimate of a loss of $0.87, but worse than a loss of $0.49 per share a year ago, indicating an earnings surprise of +3.45% [1] - The company posted revenues of $22.4 million for the quarter ended June 2025, missing the Zacks Consensus Estimate by 53.28%, and a significant decline from year-ago revenues of $76.5 million [2] - Over the last four quarters, Arvinas has surpassed consensus EPS estimates four times and topped consensus revenue estimates two times [2] Stock Outlook - Arvinas shares have declined approximately 60.3% since the beginning of the year, contrasting with the S&P 500's gain of 7.1% [3] - The company's earnings outlook is crucial for investors, as it includes current consensus earnings expectations for upcoming quarters and any recent changes to these expectations [4] - The current consensus EPS estimate for the coming quarter is -$0.75 on revenues of $41.04 million, and for the current fiscal year, it is -$1.50 on revenues of $294.99 million [7] Industry Context - The Medical - Biomedical and Genetics industry, to which Arvinas belongs, is currently ranked in the bottom 42% of over 250 Zacks industries, suggesting that the industry outlook may negatively impact stock performance [8] - Empirical research indicates a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can be tracked by investors or through tools like the Zacks Rank [5][6]

Core Insights - MarketAxess (MKTX) reported quarterly earnings of $2 per share, exceeding the Zacks Consensus Estimate of $1.94 per share, and up from $1.72 per share a year ago, representing an earnings surprise of +3.09% [1] - The company achieved revenues of $219.46 million for the quarter ended June 2025, surpassing the Zacks Consensus Estimate by 0.59% and increasing from $197.66 million year-over-year [2] - MarketAxess has consistently surpassed consensus EPS estimates over the last four quarters, indicating strong performance [2] Financial Performance - The earnings surprise of +3.09% for the recent quarter follows a previous surprise of +2.75% when the company reported earnings of $1.87 per share against an expectation of $1.82 [1][2] - The current consensus EPS estimate for the upcoming quarter is $1.87, with projected revenues of $217.2 million, and for the current fiscal year, the EPS estimate is $7.50 on revenues of $866.46 million [7] Market Position - Despite the strong earnings report, MarketAxess shares have underperformed the market, losing about 8.1% since the beginning of the year, while the S&P 500 has gained 7.1% [3] - The Zacks Industry Rank places the Financial - Investment Bank sector in the top 5% of over 250 Zacks industries, suggesting a favorable outlook for companies within this sector [8]

Company Performance - DNOW reported quarterly earnings of $0.27 per share, exceeding the Zacks Consensus Estimate of $0.22 per share, and showing an increase from $0.25 per share a year ago, representing an earnings surprise of +22.73% [1] - The company posted revenues of $628 million for the quarter ended June 2025, surpassing the Zacks Consensus Estimate by 2.19%, although this is a slight decrease from year-ago revenues of $633 million [2] - DNOW has consistently outperformed consensus EPS and revenue estimates over the last four quarters [2] Stock Performance - DNOW shares have increased approximately 17.1% since the beginning of the year, compared to a 7.1% gain in the S&P 500 [3] - The current consensus EPS estimate for the upcoming quarter is $0.22 on revenues of $618.25 million, and for the current fiscal year, it is $0.86 on revenues of $2.42 billion [7] Industry Outlook - The Manufacturing - General Industrial industry, to which DNOW belongs, is currently ranked in the top 16% of over 250 Zacks industries, indicating a favorable outlook [8] - Empirical research suggests a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can impact DNOW's stock performance [5]

Core Viewpoint - MRC Global reported quarterly earnings of $0.25 per share, exceeding the Zacks Consensus Estimate of $0.23 per share, but down from $0.31 per share a year ago, indicating an earnings surprise of +8.70% [1] Financial Performance - The company posted revenues of $798 million for the quarter ended June 2025, surpassing the Zacks Consensus Estimate by 3.35%, although this is a decrease from year-ago revenues of $832 million [2] - Over the last four quarters, MRC has surpassed consensus EPS estimates three times and topped consensus revenue estimates three times [2] Stock Performance - MRC shares have increased approximately 12.4% since the beginning of the year, outperforming the S&P 500's gain of 7.1% [3] Future Outlook - The company's earnings outlook is crucial for investors, with current consensus EPS estimates of $0.32 for the coming quarter and $0.87 for the current fiscal year, alongside revenues of $832.9 million and $3.04 billion respectively [7] - The estimate revisions trend for MRC was favorable ahead of the earnings release, resulting in a Zacks Rank 2 (Buy) for the stock, indicating expected outperformance in the near future [6] Industry Context - The Steel - Pipe and Tube industry, to which MRC belongs, is currently in the top 23% of over 250 Zacks industries, suggesting a positive outlook as the top 50% of Zacks-ranked industries outperform the bottom 50% by more than 2 to 1 [8]

Core Viewpoint - Fortrea Holdings Inc. reported quarterly earnings of $0.19 per share, significantly exceeding the Zacks Consensus Estimate of $0.06 per share, and showing a turnaround from a loss of $0.03 per share a year ago, indicating strong performance in the latest quarter [1][2] Financial Performance - The company achieved revenues of $710.3 million for the quarter ended June 2025, surpassing the Zacks Consensus Estimate by 12.60% and reflecting an increase from $662.4 million in the same quarter last year [2] - Over the last four quarters, Fortrea has exceeded consensus EPS estimates two times and topped revenue estimates three times [2] Stock Performance - Fortrea Holdings Inc. shares have declined approximately 64.8% since the beginning of the year, contrasting with the S&P 500's gain of 7.1% [3] - The stock currently holds a Zacks Rank 3 (Hold), suggesting it is expected to perform in line with the market in the near future [6] Future Outlook - The current consensus EPS estimate for the upcoming quarter is $0.14 on revenues of $607.87 million, while for the current fiscal year, the estimate is $0.42 on revenues of $2.5 billion [7] - The outlook for the Medical - Biomedical and Genetics industry, where Fortrea operates, is currently in the bottom 42% of over 250 Zacks industries, which may impact stock performance [8]

Core Viewpoint - Perrigo reported quarterly earnings of $0.57 per share, missing the Zacks Consensus Estimate of $0.59 per share, but showing an increase from $0.53 per share a year ago, indicating a -3.39% earnings surprise [1] - The company posted revenues of $1.06 billion for the quarter, missing the Zacks Consensus Estimate by 2.63%, and a slight decrease from $1.07 billion year-over-year [2] Financial Performance - Over the last four quarters, Perrigo has surpassed consensus EPS estimates two times [2] - The company has not been able to beat consensus revenue estimates over the last four quarters [2] - The current consensus EPS estimate for the upcoming quarter is $0.79 on revenues of $1.12 billion, and for the current fiscal year, it is $3.04 on revenues of $4.44 billion [7] Stock Performance and Outlook - Perrigo shares have increased by approximately 3.5% since the beginning of the year, compared to the S&P 500's gain of 7.1% [3] - The company's earnings outlook and management's commentary on the earnings call will be crucial for future stock price movements [3][4] - The estimate revisions trend for Perrigo was favorable ahead of the earnings release, resulting in a Zacks Rank 2 (Buy) for the stock, indicating expected outperformance in the near future [6] Industry Context - The Medical - Products industry, to which Perrigo belongs, is currently in the bottom 41% of over 250 Zacks industries, which may impact stock performance [8] - Another company in the same industry, Cresco Labs Inc., is expected to report a quarterly loss of $0.04 per share, with revenues projected to decline by 11.1% year-over-year [9]

分组1 - Hippo Holdings Inc. reported quarterly earnings of $0.65 per share, exceeding the Zacks Consensus Estimate of a loss of $0.65 per share, and showing improvement from a loss of $1.64 per share a year ago, resulting in an earnings surprise of +200.00% [1] - The company achieved revenues of $117.3 million for the quarter ended June 2025, surpassing the Zacks Consensus Estimate by 1.59% and increasing from $89.6 million year-over-year [2] - Over the last four quarters, Hippo Holdings has surpassed consensus EPS estimates three times and topped consensus revenue estimates four times [2] 分组2 - The stock's immediate price movement will depend on management's commentary during the earnings call and the sustainability of earnings expectations [3][4] - Hippo Holdings shares have increased approximately 3.3% since the beginning of the year, while the S&P 500 has gained 7.1% [3] - The current consensus EPS estimate for the upcoming quarter is -$0.31 on revenues of $122.53 million, and for the current fiscal year, it is -$2.86 on revenues of $477.03 million [7] 分组3 - The Zacks Industry Rank indicates that the Insurance - Multi line sector is currently in the top 39% of over 250 Zacks industries, suggesting that stocks in the top 50% outperform those in the bottom 50% by more than 2 to 1 [8] - The estimate revisions trend for Hippo Holdings was favorable ahead of the earnings release, resulting in a Zacks Rank 2 (Buy) for the stock, indicating expected outperformance in the near future [6]

Core Insights - Claritev Corporation (CTEV) reported quarterly earnings of $0.32 per share, significantly beating the Zacks Consensus Estimate of a loss of $2.69 per share, and improving from a loss of $1.2 per share a year ago, resulting in an earnings surprise of +111.90% [1] - The company generated revenues of $241.57 million for the quarter ended June 2025, exceeding the Zacks Consensus Estimate by 4.38% and showing an increase from $233.48 million in the same quarter last year [2] - Claritev Corporation's stock has increased approximately 167.4% year-to-date, outperforming the S&P 500's gain of 7.1% [3] Earnings Outlook - The future performance of Claritev Corporation's stock will largely depend on management's commentary during the earnings call and the company's earnings outlook [4] - The current consensus EPS estimate for the upcoming quarter is -$2.62 on revenues of $231.53 million, and for the current fiscal year, it is -$12.20 on revenues of $928.06 million [7] Industry Context - The Medical Info Systems industry, to which Claritev Corporation belongs, is currently ranked in the top 30% of over 250 Zacks industries, indicating a favorable outlook compared to lower-ranked industries [8] - The correlation between near-term stock movements and earnings estimate revisions suggests that tracking these revisions can provide insights into stock performance [5]